Nociception Level Index Monitoring During Cesarean Section (NOL-CS)
Effect of Nociception Level Index-Guided Intraoperative Analgesia on Postoperative Pain Management During Elective Cesarean Section
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
Postoperative pain following cesarean section remains an important clinical concern because inadequate analgesia may delay maternal recovery, increase opioid consumption, and negatively affect early breastfeeding and maternal-infant bonding. Conventional intraoperative monitoring does not directly assess nociceptive responses, making individualized analgesic administration challenging.
The Nociception Level (NOL) index is a multiparametric monitoring system that integrates photoplethysmography, galvanic skin response, peripheral temperature, and accelerometer signals to provide an objective assessment of nociception during anesthesia. This technology may enable more individualized opioid administration based on the patient's nociceptive response.
In this prospective randomized controlled trial, patients undergoing elective cesarean section under general anesthesia were randomized to receive either NOL-guided intraoperative analgesia or standard intraoperative monitoring. In the intervention group, fentanyl administration after fetal delivery was guided by the NOL index, whereas patients in the control group received conventional hemodynamic-guided analgesia.
Postoperative pain was evaluated using the visual analog scale (VAS) at predefined time points during the first 24 postoperative hours. Rescue opioid requirements, total postoperative analgesic consumption, and time to first breastfeeding were also recorded. The study was designed to determine whether NOL-guided analgesia could improve early postoperative pain control and reduce postoperative opioid requirements compared with conventional monitoring.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Sultangazi
-
Istanbul, Sultangazi, Tyrkia (Türkiye), 34256
- University of Health Sciences Türkiye Haseki Training and Research Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria:
- Female patients undergoing elective cesarean section under general anesthesia.
- Ability to provide written informed consent.
Exclusion Criteria:
- Refusal to participate.
- Emergency cesarean section.
- High-risk pregnancy (including hypertensive disorders of pregnancy, diabetes mellitus, preterm labor, or fetal growth restriction).
- Placental abnormalities.
- History of allergy to any study medication.
- History of malignant hyperthermia.
- Alcohol or substance abuse.
- Severe cardiac disease or severe arrhythmia.
- Peripheral vascular disease.
- Renal or hepatic failure.
- Contraindication to corticosteroid administration.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: NOL-Guided Analgesia Group
Patients undergoing elective cesarean section under general anesthesia were monitored intraoperatively using the Nociception Level (NOL) index in addition to standard monitoring.
After fetal delivery, fentanyl was administered in 25-mcg boluses when the NOL value remained above 25 for more than 1 minute, with a minimum interval of 5 minutes between doses.
|
The Nociception Level (NOL) index was used to guide intraoperative fentanyl administration after fetal delivery.
|
|
Aktiv komparator: Standard Monitoring Group
Patients undergoing elective cesarean section under general anesthesia received standard intraoperative monitoring.
Intraoperative analgesic management was performed according to conventional clinical practice without NOL index guidance.
|
Standard intraoperative monitoring was used for routine anesthetic and analgesic management without NOL index guidance.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Postoperative pain intensity assessed using the Visual Analog Scale (VAS)
Tidsramme: 10 minutes, 30 minutes, 4 hours, 8 hours, 12 hours, and 24 hours after surgery
|
Postoperative pain intensity was evaluated using a 10-cm Visual Analog Scale (VAS), where 0 indicated no pain and 10 indicated the worst imaginable pain.
|
10 minutes, 30 minutes, 4 hours, 8 hours, 12 hours, and 24 hours after surgery
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Time to first breastfeeding
Tidsramme: Within the first postoperative hour
|
The time elapsed from the end of surgery until the first successful breastfeeding was recorded in minutes.
|
Within the first postoperative hour
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Need for rescue analgesia
Tidsramme: Within the first 24 hours after surgery
|
The proportion of patients requiring additional postoperative analgesia was recorded.
|
Within the first 24 hours after surgery
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- HASEKI-36-408-2023
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Nociception Level Index Monitoring
-
Centre Hospitalier Universitaire de Saint EtienneAvsluttetSmerte | Alzheimers sykdom | Autonomisk nervesystemsykdomFrankrike
-
Universitätsklinikum Hamburg-EppendorfRekrutteringSmerter, postoperativt | Opioidbruk | Nociseptiv smerte | Gjenopprettingsperiode for anestesi | Analgesi, postoperativTyskland
-
University Hospital, BordeauxFullførtVæskerespons | VolumutvidelseFrankrike
-
Radboud University Medical CenterRekrutteringPediatrisk anestesi | Anestesi | Nociseptiv smerte | Nociception MonitoringNederland
-
Investigation Group Anesthesia, Resuscitation,...RekrutteringSkrøpelighet i voksenkirurgiSpania
-
McGill UniversityMaisonneuve-Rosemont Hospital; Jewish General HospitalHar ikke rekruttert ennåKritisk sykdom | Smerte, akutt | Oppførsel | Nociseptiv smerte
-
University Hospital, LilleClinical Investigation Centre for Innovative Technology Network; Fondation...FullførtSmerte | Cerebral parese | BarnFrankrike
-
Institut de Cancérologie de LorraineFullført
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinFullførtKvalifisert for dagtilfellekirurgiFrankrike
-
İstanbul Yeni Yüzyıl ÜniversitesiHar ikke rekruttert ennåSmerte | Intensivavdelingens syndrom | Stressrelatert lidelse